Ozzy Osbourne, famous for biting heads off bats, heavy metal music and a reality TV show, announced he has Parkinson's disease. A Parkinson's specialist explains the disease and recent advances.
Academic rigor, journalistic flair
Articles on Parkinson's disease
Displaying 1 - 20 of 73 articles
High prescription drug costs are a widespread concern for consumers and policymakers. For patients who need specialty drugs, though, the problem is even worse, with no relief in sight.
From dementia to depression to drug addiction, artificial brain stimulation has been hailed as a landmark medical technology for the future. But safeguards are needed if we want the benefits without the risks.
About one in six people who take the most common medication for Parkinson's disease will develop addictive behaviours. We found whether this happens depends on a person's unique brain structure.
Researchers are looking for ways to determine who's most at risk for dementia and also ways to detect it early. A scientist who has studied low blood pressure makes a case for a link between the two.
When people lose their speech, they can stop working and friends can drift away. Here's what we can do to help them get the rehabilitation they need.
Parkinson's disease is twice as common in men than in women. A sex gene called SRY, found only in men, could go some way to explaining this – and might pave the way for potential treatments.
Some treatments for neurodegenerative diseases involve inserting wires into the brain and zapping certain brain cells with electricity. But what if you could do the same thing using sound waves?
An enzyme called TOR could hold the secret to a longer, healthier life.
Thomas Durcan's lab is growing 3D mini-brains in the search for a cure for Parkinson's disease. Over the next year he is giving all his lab's protocols, methods and results away.
New study challenges traditional view of Parkinson's disease.
A number of contradictory studies have found a link between Parkinson's and having your appendix out.
Changes in bowel habits occur up to 20 years before the onset of Parkinson's.
We blame electronic devices for our increasingly sedentary behaviours. So why not harness them to study our movement patterns and tackle urgent health crises?
Insurance companies sometimes try to cut costs by substituting less expensive drugs for a specific drug prescription. That's raising problems in many cases, and actually causing harm.
The Gila monster gave humans a treatment for diabetes. What other medical miracles are we losing by failing to protect wildlife and ecosystems?
A new type of drug blocks the destruction of neurons in the eye, preventing blindness. The researchers hope that the same therapy can be applied to other common neurodegenerative diseases.
Media pioneer Ted Turner's announcement that he has Lewy body dementia brings the illness into the spotlight, which is rare. A neurologist explains why it's hard to even get a correct diagnosis.
We've got better at managing the health risks of traditional drugs of abuse, but novel psychoactive substances, or 'legal highs', are a dangerous unknown.
Alan Alda announced July 31, 2018 that he's been living with Parkinson's Disease. An expert on the disease explains new drugs and treatments.
Top contributors
-
Professor of Neuroscience, University of Reading
-
Professor of Neurology, University of Florida
-
Honorary (Professorial Fellow) at the Centre for Neuroscience, University of Melbourne
-
Senior Research Fellow, Monash University
-
Assistant Professor, Neurology, University of Florida
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Lecturer, Monash University
-
Doctoral Student in Ageing & Neurodegeneration, Neuroscience Research Australia
-
Rob Brooks is a Friend of The Conversation.
Scientia Professor of Evolutionary Ecology; Academic Lead of UNSW's Grand Challenges Program; Director, Evolution & Ecology Research Centre, UNSW
-
Research Fellow and Lecturer, Monash University
-
Senior Research Fellow, Uehiro Centre for Practical Ethics, University of Oxford
-
Head of Neural Transplantation, Florey Institute of Neuroscience and Mental Health
-
BrainsCAN Research Fellow at Western University’s Schulich School of Medicine & Dentistry, Western University
-
Chief Executive Officer, Cooperative Research Centre for Mental Health
-
Distinguished Professor of Genetics, La Trobe University
